As of 2026-05-26, the EV/EBITDA ratio of Jiangsu Nhwa Pharmaceutical Co Ltd (002262.SZ) is 17.27. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 002262.SZ's latest enterprise value is 19,315.46 mil CNY. 002262.SZ's TTM EBITDA according to its financial statements is 1,118.50 mil CNY. Dividing these 2 quantities gives us the above 002262.SZ EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 16.9x - 40.0x | 28.1x |
| Forward P/E multiples | 10.2x - 14.5x | 11.7x |
| Fair Price | 18.98 - 45.31 | 26.85 |
| Upside | -6.3% - 123.6% | 32.5% |
| Date | EV/EBITDA |
| 2026-05-25 | 17.27 |
| 2026-05-22 | 17.56 |
| 2026-05-21 | 17.71 |
| 2026-05-20 | 17.44 |
| 2026-05-19 | 17.71 |
| 2026-05-18 | 17.55 |
| 2026-05-15 | 18.03 |
| 2026-05-14 | 18.22 |
| 2026-05-13 | 18.32 |
| 2026-05-12 | 18.35 |
| 2026-05-11 | 18.65 |
| 2026-05-08 | 18.75 |
| 2026-05-07 | 18.90 |
| 2026-05-06 | 19.11 |
| 2026-04-30 | 19.23 |
| 2026-04-29 | 19.22 |
| 2026-04-28 | 19.25 |
| 2026-04-27 | 19.05 |
| 2026-04-24 | 18.61 |
| 2026-04-23 | 18.28 |
| 2026-04-22 | 18.39 |
| 2026-04-21 | 18.10 |
| 2026-04-20 | 17.94 |
| 2026-04-17 | 19.16 |
| 2026-04-16 | 19.69 |
| 2026-04-15 | 19.66 |
| 2026-04-14 | 19.17 |
| 2026-04-13 | 18.91 |
| 2026-04-10 | 19.45 |
| 2026-04-09 | 19.29 |
| 2026-04-08 | 19.50 |
| 2026-04-07 | 19.07 |
| 2026-04-03 | 19.47 |
| 2026-04-02 | 19.72 |
| 2026-04-01 | 19.85 |
| 2026-03-31 | 19.21 |
| 2026-03-30 | 19.39 |
| 2026-03-27 | 19.19 |
| 2026-03-26 | 18.65 |
| 2026-03-25 | 18.60 |
| 2026-03-24 | 18.52 |
| 2026-03-23 | 17.99 |
| 2026-03-20 | 18.97 |
| 2026-03-19 | 19.17 |
| 2026-03-18 | 19.42 |
| 2026-03-17 | 19.51 |
| 2026-03-16 | 19.50 |
| 2026-03-13 | 19.37 |
| 2026-03-12 | 19.39 |
| 2026-03-11 | 19.38 |